Structural approaches have provided important insights into immune mechanisms and the complexity of host-pathogen interactions. This Select highlights recent studies that have, through varied structural and molecular modeling approaches, revealed fascinating aspects of innate and adaptive immunity and the strategies used by pathogens to circumvent them.
A Six-Pronged Attack
Complement is an important layer of host immune surveillance and defense against pathogens. The classical pathway of complement activation involves binding of C1q to antigenbound immunoglobulin M (IgM) or IgG molecules. This binding triggers the activation of proteases within the C1 complex and the initiation of the complement cascade that culminates in the activation of varied effector mechanisms aimed at pathogen clearance. IgM molecules exist mostly in pentamers, and this polymeric state increases the avidity of C1q binding. However, IgM requires a conformational change upon antigen binding for C1q-binding sites to become exposed. In IgG, C1q-binding sites are continuously exposed but the affinity is very low, presumably to avoid binding in the blood. Diebolder and colleagues now provide molecular insight on how IgG interacts efficiently with C1q and activates complement. On basis of structural studies, the authors hypothesized that after binding antigen, IgG molecules form hexamers, thus providing scaffolds for efficient complement activation. Mutations in the Fc interphase designed to manipulate noncovalent Fc-Fc interactions between IgG molecules significantly decreased or increased complement dependent cytotoxicity. Cryo-electron tomography of antigen-bound IgG on a membrane revealed a hexagonal arrangement with C1 bound. Interestingly, modeling of the C1-antibody hexamer complex suggested that only one of the two Fab arms of the antibody is bound to the antigen. Bispecific antibodies, designed so that one arm recognizes the antigen and the other is irrelevant for that interaction, could induce superior complement activation compared to parental antibodies, providing insight into the geometry of these interactions. The authors propose a model wherein antigen binding by IgG followed by Fc-Fc binding leads to the formation of hexamers resulting in high avidity binding of C1q. This suggests that this multimerization may provide a checkpoint, so that complement is activated only after target binding. These findings also reveal an exciting strategy for designing more effective therapeutic antibodies. Diebolder, C. A., et al. (2014 
IgE: Mover and Shaker
Immunoglobulin E (IgE) molecules play important roles in immunity to parasites and in the pathology of allergic diseases. IgE binds the FcεRI receptor on mast cells and basophils, and antigen recognition by FcεRI-bound IgE triggers the release of inflammatory mediators such as histamine. Previous structural and biophysical analyses revealed an extraordinary, acute, and asymmetrical bend in the Fc region of the molecule. This bent conformation has shaped current thinking of IgE's functions. However, biophysical analyses of Fab fragments of omalizumab (Xolair, Novartis Pharmaceuticals), an anti-igE monoclonal antibody that is effective in the treatment of asthma and other allergic diseases, suggested that IgE may not always exist in this acutely bent conformation. In a recent study, Drinkwater et al. (2104) capture a fully extended conformation of IgE, provoking a re-examination of how IgE works in vivo. In IgG molecules, the antigen-binding Fab segments are connected to the receptorbinding Fc chains via a flexible linker. The Fc regions of IgE molecules contain an additional pair of domains, (Cε2) 2 in place of this flexible linker; in the bent conformation, the Cε2 domain pair is folded back onto the Cε3-Cε4 domains. The authors generated an IgG antibody Fab fragment that binds IgE-Fc (aεFab), and resolution of the crystal structure of aεFab-bound IgE-Fc reveals an extended, symmetrical conformation more similar to that of IgG molecules. Using molecular dynamics simulations and a variety of biophysical measurements, the authors show that this extended conformation is found in solution and would result, at a molecular level, from a ''flipping'' of the Cε2 domains from one side of the molecule to the other. Interestingly, allosteric constraints prevent this extended conformation from binding to the FcεRI receptor. Molecular modeling approaches suggest that the membrane-bound IgE, which would function as a B cell receptor, displays an extended conformation. Further studies should reveal how this conformational diversity impacts the biological functions of IgE. Drinkwater, N., et al. (2014) . Nat. Struct. Mol. Biol. 21, [397] [398] [399] [400] [401] [402] [403] [404] 
A Resourceful Invader
Upon infection, the human pathogen Shigella spp injects an array of bacterial effector proteins into the host cell. These proteins in turn manipulate host pathways so as to facilitate bacterial entry and survival and replication, and many of them act to inhibit innate immune pathways in the cell. One of these effector proteins is the kinase OspG, which inhibits degradation of a negative regulator of the NFkB pathway. To be effective in the host-cell environment, bacterial enzymes are thought be highly active. OspG, however, exhibits weak kinase activity in vitro. In a recent study, Pruneda et al. reveal that OspG binds to and repurposes host E2Ubiquitin (Ub) conjugates, using this interaction to enhance its kinase activity. The authors cocrystallized OspG in complex with UbcH5c-OUb, showing that OspG interacts with both UbcH5c and Ub. These interactions stabilize the kinase, compensating for the minimal intraprotein interactions within OspG itself and providing context for OspG's minimal kinase domain. Furthermore, the stabilized structure is highly active. The authors show that OspG can interact with various E2Ub conjugates. Effector kinases from Yersinia and enterohemorrhagic E. coli exhibit high-sequence homology to OspG. Thus, the co-opting mechanism identified may be broadly used by bacterial pathogens. Pruneda, J.N., et al. (2014) . EMBO J. 33, [437] [438] [439] [440] [441] [442] [443] [444] [445] [446] [447] [448] [449] .
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Cε2 domains display extreme flexibility from the bent (in violet/blue) to the extended structure (in red), relative to the Cε3 and Cε4 domains. Image courtesy of N. Drinkwater and B. Sutton.
Structure of the OspG/UbcH5cUb complex with ATP modeled into the kinase active site. Image courtesy of P. Brzovic.
